Global Rare Disease Market is estimated to be US$ 547.5 billion by 2030 with a CAGR of 13.1% during the forecast period – by PMI

Ads

You May Also Like

Argos Announces $1.5 Million Equity Investment by Lummy (Hong Kong), Ltd.

DURHAM, N.C., Jan. 08, 2018 (GLOBE NEWSWIRE) -- Argos Therapeutics Inc. (NASDAQ:ARGS), an immuno-oncology ...